297. Alagille syndrome Clinical trials / Disease details
Clinical trials : 45 / Drugs : 21 - (DrugBank : 10) / Drug target genes : 3 - Drug target pathways : 5
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05488067 (ClinicalTrials.gov) | March 22, 2022 | 1/8/2022 | Atorvastatin Therapy on Xanthoma in Alagille Syndrome | The Safety and Efficacy of Atorvastatin on Xanthoma in Alagille Syndrome | Alagille Syndrome;Atorvastatin;Xanthoma | Drug: atorvastatin | Children's Hospital of Fudan University | NULL | Recruiting | 1 Day | 17 Years | All | 10 | Phase 4 | China |